Recent News

Lupus Ontario Education Symposium 2026 to Explore the Future of Lupus Care

Lupus Ontario will host its 2026 Education Symposium, a two-day virtual event bringing together leading...

Lupus Ontario Patient Experience Survey: Caregiving Experiences and Challenges At the end of 2025, Lupus...

Step Forward for Lupus Research Across Ontario Join the WALK for Lupus Ontario — our...

Lupus Ontario Patient Experience Survey: Flares and Hospitalization At the end of 2025, Lupus Ontario...

Lupus Symptoms, Comorbidities and Major Organ Impacts In the last quarter, Lupus Ontario launched a...

Diagnosis Summary In the last quarter, Lupus Ontario launched a Patient Experience Survey to better...

On January 22, 2026, Health Canada has approved Gazyva® (obinutuzumab) for the treatment of adult...

With this approval, pediatric patients aged five years and older with active lupus nephritis will...